Turn this role into an interview — a resume and cover letter built around what this employer wants.
CHEO hosts NSO and seeks a full-time Clinical Scientist in the molecular laboratory for newborn screening. The role is hybrid, with ~40% from home and 60% on-site at the Children's Hospital of Eastern Ontario.
Compensation ranges from CAD 173,491 to CAD 202,117 per year, commensurate with academic rank. The incumbent interprets molecular data, collaborates with leadership, evaluates variants, drafts reports, and leads assay development, QA, and education activities.
Clinical Scientist, Newborn Screening Ontario - Permanent Full-Time (1.0) / Chercheuse ou chercheur clinique en sciences, Dépistage neonatal Ontario - permanente à temps plein (1.0)
CHEO hosts several provincial and federal programs including Newborn Screening Ontario (NSO). NSO provides a comprehensive program of analysis, follow-up, education, research and development, ensuring that every newborn receives the highest quality screening and care. At NSO, we are leaders in screening through research, development, education, and innovation. The multidisciplinary team at NSO comprises dedicated clinical, laboratory, management, and administrative staff.
We are seeking a full-time, permanent clinical scientist within the molecular laboratory. The position is hybrid; approximately 40% can be performed from home and 60% is on site at the Children's Hospital of Eastern Ontario.
Compensation Pay Range: $173,491 - $202,117 commensurate with academic rank
The core responsibilities of the Clinical Scientist – Molecular are the interpretation and reporting of data from the molecular laboratory of Newborn Screening Ontario. This includes:
This is an academic position. The Clinical Molecular Scientist is eligible for an appointment at the University of Ottawa commensurate with experience and may have the opportunity to develop a research program and participate in teaching at CHEO and/or the University of Ottawa.
Effective March 29, 2021, CHEO will conduct a more comprehensive pre-screening and evaluation process. This process may include more varied and multidimensional testing such as a written test, practical exam, or other assessment. All candidates who meet the essential and preferred qualifications may be tested.
Bilingualism (French/English) will be validated by a language proficiency assessment conducted by a third party provider. Candidates will be required to meet the minimum linguistic profile prior to the date of hire.
Ottawa is built on un-ceded Algonquin Anishinaabe territory. The peoples of the Algonquin Anishinabek Nation have lived on this territory for millennia and we honour them and this land. Their culture and presence have nurtured and continue to nurture this land. CHEO also honours all First Nations, Inuit and Métis peoples and their valuable past and present contributions to this land.
CHEO is one of the few stand-alone, global leaders in pediatric health and is home to more than 6,500 staff, clinicians, scientists and researchers, as well as volunteers – all of whom work together to help children and youth achieve their best lives. Within its own walls and through partnerships with community providers, CHEO has transformed from a 20th century acute care hospital into a 21st century integrated child and youth health system.
Ranked in the top 1% of Canadian hospitals for the digitization of its clinical infrastructure, CHEO combines excellence in clinical care, research, and education to advance seamless care that’s provided where, when, and how it is needed. CHEO's Research Institute is dedicated to world-class clinical, translational, and basic science research covering a wide range of children's health concerns. CHEO has been named Canada's best health-care employer by Forbes in 2024, 2025 and 2026 and is ranked second among Canadian hospitals on its list of Canada's Best Employers for multiple consecutive years. For the 14th consecutive year in a row, the editors of Canada's Top 100 Employers has recognized CHEO as a top employer in the National Capital Region. Every year CHEO helps more than 500,000 children and youth from Eastern Ontario, western Quebec, Nunavut and Northern Ontario.
Le CHEO héberge plusieurs programmes provinciaux et fédéraux tels que Dépistage néonatal Ontario (DNO). DNO est un programme complet d’analyse, de suivi, d’éducation, de recherche et de développement qui vise à ce que chaque nouveau-né reçoive les meilleurs soins et la meilleure qualité en matière de dépistage. En outre, DNO est un chef de file en dépistage grâce à la recherche, au développement, à l’éducation et à l’innovation. L’équipe multidisciplinaire de DNO est composée de personnel clinique, administratif, de laboratoire et de gestion dévoué.
Nous sommes à la recherche d’une chercheuse ou d’un chercheur clinique pour un poste permanente à temps plein au laboratoire moléculaire. Le poste est hybride; environ 40 % des tâches peuvent être effectuées à domicile et 60 % des tâches se font sur place au Centre hospitalier pour enfants de l’est de l’Ontario.
Il s’agit d’un poste universitaire. La chercheuse ou le chercheur clinique en sciences moléculaires est admissible à une nomination à l’Université d’Ottawa qui correspond à son expérience et pourrait avoir la possibilité de créer un programme de recherche et de participer à l’enseignement au CHEO ou à l’Université d’Ottawa.
À partir du 29 mars 2021, CHEO mènera un processus de présélection et d’évaluation plus complet. Ce processus peut comprendre des tests plus variés et multidimensionnels tels qu’un test écrit, un examen pratique ou une autre évaluation. Tous les candidats qui satisfont aux qualifications essentielles et préférées peuvent être testés.
La validation du bilinguisme (français-anglais) se fera au moyen d’une évaluation des compétences linguistiques menée par un fournisseur externe. Les candidats devront satisfaire au profil linguistique minimum de leur poste avant la date d’embauche.